Literature DB >> 26252958

Identification of a novel mutation associated with familial adenomatous polyposis and colorectal cancer.

Fei-Feng Li1, Zheng Liu2, Peng Yan2, Xin Shao2, Xia Deng1, Christine Sam3, Ying-Gang Chen2, Yong-Peng Xu2, Xi-Shan Wang2, Gui-Yu Wang2, Shu-Lin Liu1.   

Abstract

Colorectal cancer (CRC) is among the most fatal forms of solid tumor in men and women. While the majority of diagnosed CRC cases are sporadic, 15‑25% of patients have a family history of adenomatous polyposis and CRC; however, the associated gene mutations remain largely unidentified. The aim of the present study was to investigate the genomes of a four‑generational Chinese Han family with familial adenomatous polyposis and CRC to identify the potential genetic anomalies associated with the disease. Diagnoses were made by physical and enteroscopic examinations of all the family members. Mutational analyses of the potential CRC‑associated genes were carried out by direct gene sequencing, and the statistically significant differences in polymorphisms between normal and diseased populations were determined. Multiple sequence alignment and protein modeling were conducted using the Vector NTI and DNAMAN software tools. Clinical and pathological features of all the examined patients were consistent with typical familial adenomatous polyposis (FAP) syndrome. From the genomes of these family members, a 131564T>C (p.1125Val>Ala) mutation was identified in exon 15 of the APC gene, and a 1126G>C (p.324Gln>His) mutation was identified in exon 12 of the MUTYH gene. The 131564T>C mutation co‑segregated with the affected individuals in the family and was specifically associated with the incidence of CRC (P=0.018<0.05). The 1125Val residue was highly conserved in the APC protein, and the p.1125Val>Ala mutation led to changes in the secondary structure and hydrophilicity of the APC protein. In conclusion, the APC gene mutation 131564T>C is associated with FAP and the pathogenesis of CRC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26252958     DOI: 10.3892/ijmm.2015.2303

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  6 in total

1.  Combined effects of age and polymorphisms in Notch3 in the pathogenesis of cerebral infarction disease.

Authors:  Chun-Yu Zhu; Yue Wang; Qing-Xuan Zeng; Yu Qian; Huan Li; Zi-Xia Yang; Ya-Mei Yang; Qiong Zhang; Fei-Feng Li; Shu-Lin Liu
Journal:  Metab Brain Dis       Date:  2016-07-02       Impact factor: 3.584

2.  Characterization of variations in IL23A and IL23R genes: possible roles in multiple sclerosis and other neuroinflammatory demyelinating diseases.

Authors:  Fei-Feng Li; Xi-Dong Zhu; Peng Yan; Mei-Hua Jin; Hui Yue; Qiong Zhang; Jin Fu; Shu-Lin Liu
Journal:  Aging (Albany NY)       Date:  2016-11-26       Impact factor: 5.682

3.  Polymorphisms in the CHIT1 gene: Associations with colorectal cancer.

Authors:  Fei-Feng Li; Peng Yan; Zhi-Xun Zhao; Zheng Liu; Da-Wei Song; Xing-Wang Zhao; Xi-Shan Wang; Gui-Yu Wang; Shu-Lin Liu
Journal:  Oncotarget       Date:  2016-06-28

4.  Targeted next-generation sequencing approach for molecular genetic diagnosis of hereditary colorectal cancer: Identification of a novel single nucleotide germline insertion in adenomatous polyposis coli gene causes familial adenomatous polyposis.

Authors:  Dan Wang; Shengyun Liang; Xipeng Zhang; Subrata Kumar Dey; Yuwei Li; Chen Xu; Yongjun Yu; Mingsen Li; Guoru Zhao; Zhao Zhang
Journal:  Mol Genet Genomic Med       Date:  2018-12-06       Impact factor: 2.183

5.  Different effection of p.1125Val>Ala and rs11954856 in APC on Wnt signaling pathway.

Authors:  Fei-Feng Li; Zhi-Xun Zhao; Peng Yan; Song Wang; Zheng Liu; Qiong Zhang; Xiao-Ning Zhang; Chang-Hao Sun; Xi-Shan Wang; Gui-Yu Wang; Shu-Lin Liu
Journal:  Oncotarget       Date:  2017-08-05

6.  RBPJ polymorphisms associated with cerebral infarction diseases in Chinese Han population: A Clinical Trial/Experimental Study (CONSORT Compliant).

Authors:  Qiong Zhang; Jie Zhou; Hong Lei; Chun-Yu Zhu; Fei-Feng Li; Dong Zheng; Shu-Lin Liu
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.